First Trust NYSE Arca Biotechnology Index Fund Rating $173.44 +3.26 (+1.92%) (As of 11/1/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy2.66Holdings in FBT have an aggregate rating of Moderate Buy based on 507 analyst ratings issued in the past year covering 30 companies (99.8% of the portfolio).FBT Aggregate Price Target$214.0323.40% UpsideHigh Prediction$279.78Average Prediction$214.03Low Prediction$149.05Holdings in FBT have an aggregate price target of $214.03 and a range of $149.05 to $279.78 covering 30 companies (99.8% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.66%EXELExelixis$34.12+2.8%4.6514 of 5 stars2.65$31.44 -7.8%20Earnings ReportAnalyst ForecastInsider SellingAnalyst RevisionNews CoverageHigh Trading Volume3.62%CPRXCatalyst Pharmaceuticals$21.89+0.4%4.7788 of 5 stars3.00$29.50 34.8%6Upcoming Earnings3.62%SRPTSarepta Therapeutics$123.29-2.2%4.9529 of 5 stars2.95$182.95 48.4%21Upcoming Earnings3.57%GILDGilead Sciences$89.51+0.8%4.9348 of 5 stars2.65$86.85 -3.0%23Upcoming EarningsAnalyst Forecast3.55%CORTCorcept Therapeutics$47.62-2.8%4.9202 of 5 stars3.00$65.25 37.0%5Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.53%ALNYAlnylam Pharmaceuticals$273.91+2.7%3.9357 of 5 stars2.75$294.50 7.5%24Analyst ForecastShort Interest ↑News Coverage3.51%ARGXargenx$595.58+1.6%2.5517 of 5 stars2.83$596.78 0.2%23Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage3.42%NBIXNeurocrine Biosciences$122.21+1.6%4.9258 of 5 stars2.83$163.91 34.1%24Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.42%BMRNBioMarin Pharmaceutical$66.60+1.1%4.975 of 5 stars2.68$94.45 41.8%22Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage3.41%ITCIIntra-Cellular Therapies$86.54+2.1%4.6002 of 5 stars2.85$96.62 11.6%13Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage3.38%EXASExact Sciences$69.80+1.3%4.2415 of 5 stars2.94$80.64 15.5%16Upcoming EarningsAnalyst ForecastShort Interest ↑3.37%INCYIncyte$76.13+2.7%4.1207 of 5 stars2.38$76.74 0.8%21Earnings ReportAnalyst UpgradeShort Interest ↑News Coverage3.35%VRTXVertex Pharmaceuticals$471.12-1.0%3.4466 of 5 stars2.48$492.50 4.5%29Upcoming EarningsAnalyst Forecast3.34%UTHRUnited Therapeutics$374.02+0.0%4.5809 of 5 stars2.73$370.86 -0.8%15Earnings ReportAnalyst ForecastInsider SellingNews CoveragePositive News3.33%RGENRepligen$138.61+3.2%4.8043 of 5 stars2.80$190.25 37.3%10News CoveragePositive News3.33%BIIBBiogen$173.79-0.1%4.8404 of 5 stars2.62$262.83 51.2%26Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage3.32%ILMNIllumina$149.76+3.9%4.1502 of 5 stars2.67$154.33 3.1%24Upcoming Earnings3.31%GMABGenmab A/S$22.56+1.1%4.6427 of 5 stars2.67$45.20 100.4%12Upcoming Earnings3.31%ACADACADIA Pharmaceuticals$14.81+1.5%4.5144 of 5 stars2.65$25.56 72.6%17Upcoming Earnings3.28%AMGNAmgen$319.22-0.3%4.5959 of 5 stars2.50$333.50 4.5%24Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision3.18%HALOHalozyme Therapeutics$57.15+13.0%4.7142 of 5 stars2.60$61.00 6.7%10Analyst ForecastShort Interest ↑News CoverageGap UpHigh Trading Volume3.17%ALKSAlkermes$26.47+3.0%4.89 of 5 stars2.50$34.90 31.8%10Short Interest ↓3.17%BNTXBioNTech$111.48-1.4%2.1653 of 5 stars2.71$135.54 21.6%14Upcoming Earnings3.13%NTRANatera$124.16+2.6%2.9221 of 5 stars3.00$125.69 1.2%16Analyst ForecastInsider SellingNews Coverage3.12%WATWaters$387.21+19.8%3.8705 of 5 stars2.29$342.58 -11.5%14Earnings ReportNews CoverageGap UpHigh Trading Volume3.12%REGNRegeneron Pharmaceuticals$843.60+0.6%4.8453 of 5 stars2.73$1,090.24 29.2%22Analyst ForecastAnalyst RevisionNews Coverage3.10%BGNEBeiGene$204.21+0.8%1.9268 of 5 stars2.71$246.21 20.6%7Analyst Revision3.09%BRKRBruker$59.29+4.7%4.9061 of 5 stars2.55$80.82 36.3%11Upcoming EarningsGap Up3.09%MRNAModerna$54.63+0.5%4.4772 of 5 stars2.10$94.65 73.3%20Upcoming Earnings3.04%MTDMettler-Toledo International$1,342.09+3.9%3.835 of 5 stars1.88$1,363.75 1.6%8Upcoming EarningsNews CoverageGap Up This page (NYSEARCA:FBT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
